The competitive NMDA receptor antagonist CGS19755 blocks the development of sensitization of the locomotor and dopamine activating effects of amphetamine
Jake Matthews, C.; Jolly, D.C.; Queen, A.L.; Brose, J.; Vezina, P.
Society for Neuroscience Abstracts 23(1-2): 1092
1997
ISSN/ISBN: 0190-5295 Accession: 033741921
Full Text Article emailed within 1 workday: $29.90
Related References
Vezina, P.; Zurakowski, B. 1991: The nmda receptor antagonist mk 801 blocks the development of sensitization to the locomotor activating effects of amphetamine in the rat Society for Neuroscience Abstracts 17(1-2): 1430Stewart, J.; Druhan, J.P. 1993: Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist, MK-801 Psychopharmacology 110(1-2): 125-132
Jolly, D.C.; Vezina, P. 1995: MK-801 blocks the development of sensitization to the locomotor and dopamine activating effects of amphetamine Society for Neuroscience Abstracts 21(1-3): 2089
Stewart, J.; Jakob, A.; Druhan, J.P. 1992: The non-competitive NMDA antagonist, MK-801, blocks the development of sensitization to the locomotor activity effects of apomorphine Society for Neuroscience Abstracts 18(1-2): 1575
Vezina, P.; Stewart, J. 1989: The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine Brain Research 499(1): 108-120
Richtand, N.M.; Logue, A.D.; Welge, J.A.; Perdiue, J.; Tubbs, L.J.; Spitzer, R.H.; Sethuraman, G.; Geracioti, T.D. 2000: The dopamine D3 receptor antagonist nafadotride inhibits development of locomotor sensitization to amphetamine Brain Research 867(1-2): 239-242
Cook, C.D.; Newman, J.L.; Winfree, J.C.; Beardsley, P.M. 2004: Modulation of the locomotor activating effects of the noncompetitive NMDA receptor antagonist MK801 by dopamine D2/3 receptor agonists in mice Pharmacology Biochemistry and Behavior 77(2): 309-318
Svensson, A.; Pileblad, E.; Carlsson, M. 1991: A comparison between the non-competitive NMDA antagonist dizocilpine (MK-801) and the competitive NMDA antagonist D-CPPene with regard to dopamine turnover and locomotor-stimulatory properties in mice Journal of Neural Transmission. General Section 85(2): 117-129
Vezina, P.; Stewart, J. 1987: The effects of d 1 and d 2 dopamine receptor antagonists on the development of sensitization to the locomotor effects of morphine and amphetamine Society for Neuroscience Abstracts 13(1): 450
Stewart, J.; Druhan, J.P. 1991: The non competitive nmda antagonist mk801 blocks the development of conditioned activity to amphetamine amph Society for Neuroscience Abstracts 17(1-2): 1430
Hoffman, D.C.; Donovan, H. 1992: The noncompetitive NMDA antagonist MK-801 fails to block the rewarding or locomotor-activating effects of amphetamine in rats Society for Neuroscience Abstracts 18(1-2): 1575
Hutson, P.H.; Bristow, L.J.; Thorn, L.; Tricklebank, M.D. 1991: R-(+)-HA-966, a glycine/NMDA receptor antagonist, selectively blocks the activation of the mesolimbic dopamine system by amphetamine British Journal of Pharmacology 103(4): 2037-2044
Kittner, H.; Krügel, U.; Illes, P. 2001: The purinergic P2 receptor antagonist pyridoxalphosphate-6-azophenyl-2'4'-disulphonic acid prevents both the acute locomotor effects of amphetamine and the behavioural sensitization caused by repeated amphetamine injections in rats Neuroscience 102(2): 241-243
Rompree, P.P.; Perron, S. 1997: The selective neurotensin receptor antagonist, SR48692, blocks the development of amphetamine sensitization Society for Neuroscience Abstracts 23(1-2): 2145
Umathe, S.N.; Bhutada, P.S.; Raut, V.S.; Jain, N.S.; Mundhada, Y.R. 2009: The 5-HT3 receptor antagonist, ondansetron, blocks the development and expression of ethanol-induced locomotor sensitization in mice Behavioural Pharmacology 20(1): 78-83